How to increase the utilization of donor hearts?
Gespeichert in:
Verfasser / Beitragende:
[Maya Guglin]
Ort, Verlag, Jahr:
2015
Enthalten in:
Heart Failure Reviews, 20/1(2015-01-01), 95-105
Format:
Artikel (online)
Online Zugang:
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 60547866X | ||
| 003 | CHVBK | ||
| 005 | 20210128100406.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20150101xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10741-014-9434-y |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10741-014-9434-y | ||
| 100 | 1 | |a Guglin |D Maya |u Mechanical Assisted Circulation Program, University of Kentucky, Lexington, KY, USA |4 aut | |
| 245 | 1 | 0 | |a How to increase the utilization of donor hearts? |h [Elektronische Daten] |c [Maya Guglin] |
| 520 | 3 | |a Cardiac transplantation is the best treatment available for patients with end-stage cardiomyopathy. Shortage of donor hearts is the main factor limiting the use of this treatment. Many donor hearts are rejected for transplantation because of left ventricular (LV) systolic dysfunction and/or wall motion abnormalities. While some donors have true cardiomyopathy, a significant proportion has reversible LV dysfunction due to neurogenic stunned myocardium. This condition is triggered by excess of catecholamines, which is typical for brain-dead donors. If given time to recover, LV function may improve, and the heart will be suitable for transplantation. Moreover, limiting of exogenous catecholamines may facilitate the recovery. In this review, we summarize the data on LV dysfunction/wall motion abnormalities in heart donors and propose the strategy to increase the utilization of donor hearts. | |
| 540 | |a Springer Science+Business Media New York, 2014 | ||
| 690 | 7 | |a Heart failure |2 nationallicence | |
| 690 | 7 | |a Heart transplantation |2 nationallicence | |
| 690 | 7 | |a Neurogenic stunned myocardium |2 nationallicence | |
| 690 | 7 | |a Takotsubo cardiomyopathy |2 nationallicence | |
| 773 | 0 | |t Heart Failure Reviews |d Springer US; http://www.springer-ny.com |g 20/1(2015-01-01), 95-105 |x 1382-4147 |q 20:1<95 |1 2015 |2 20 |o 10741 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10741-014-9434-y |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10741-014-9434-y |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 100 |E 1- |a Guglin |D Maya |u Mechanical Assisted Circulation Program, University of Kentucky, Lexington, KY, USA |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Heart Failure Reviews |d Springer US; http://www.springer-ny.com |g 20/1(2015-01-01), 95-105 |x 1382-4147 |q 20:1<95 |1 2015 |2 20 |o 10741 | ||